Ultrasound-Guided Lateral Abdominal Wall Botulinum Toxin Injection Before Ventral Hernia Repair: A Review for Radiologists.
abdominal wall expansion
botulinum toxin
chemical component separation
ultrasound-guided procedure
ventral hernia
Journal
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
revised:
05
11
2020
received:
16
09
2020
accepted:
17
11
2020
pubmed:
16
12
2020
medline:
22
9
2021
entrez:
15
12
2020
Statut:
ppublish
Résumé
Preoperative ultrasound-guided lateral abdominal wall botulinum toxin injection is a promising method for improving patient outcomes and reducing recurrence rates after ventral hernia repair. A review of the literature demonstrates variability in the procedural technique, without current standardization of protocols. As radiologists may be increasingly asked to perform ultrasound-guided botulinum toxin injections of the lateral abdominal wall, familiarity with the procedure and current literature is necessary.
Substances chimiques
Neuromuscular Agents
0
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2019-2030Informations de copyright
© 2020 American Institute of Ultrasound in Medicine.
Références
Sauerland S, Walgenbach M, Habermalz B, Seiler CM, Miserez M. Laparoscopic versus open surgical techniques for ventral or incisional hernia repair. Cochrane Database Syst Rev 2011; 3:Cd007781.
Poulose BK, Shelton J, Phillips S, et al. Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia 2012; 16:179-183.
Ross SW, Wormer BA, Kim M, et al. Defining surgical outcomes and quality of life in massive ventral hernia repair: an international multicenter prospective study. Am J Surg 2015; 210:801-813.
Eriksson A, Rosenberg J, Bisgaard T. Surgical treatment for giant incisional hernia: a qualitative systematic review. Hernia 2014; 18:31-38.
Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, et al. Preoperative botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc 2018; 32:831-839.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.
Elstner KE, Jacombs AS, Read JW, et al. Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using botulinum toxin A. Hernia 2016; 20:209-219.
Elstner KE, Read JW, Rodriguez-Acevedo O, et al. Preoperative chemical component relaxation using Botulinum toxin A: enabling laparoscopic repair of complex ventral hernia. Surg Endosc 2017; 31:761-768.
Elstner KE, Read JW, Rodriguez-Acevedo O, Ho-Shon K, Magnussen J, Ibrahim N. Preoperative progressive pneumoperitoneum complementing chemical component relaxation in complex ventral hernia repair. Surg Endosc 2017; 31:1914-1922.
Elstner KE, Read JW, Saunders J, et al. Selective muscle botulinum toxin A component paralysis in complex ventral hernia repair. Hernia 2020; 24:287-293.
Chan DL, Ravindran P, Fan HS, et al. Minimally invasive Venetian blinds ventral hernia repair with botulinum toxin chemical component separation. ANZ J Surg 2020; 90:67-71.
Farooque F, Jacombs AS, Roussos E, et al. Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair. ANZ J Surg 2016; 86:79-83.
Hijji T, Al Shammari A, Al Hammad A, et al. Incisional hernia repair with plication and utilization of Botox injections: first case report from Saudi Arabia for a 19-year-old female. Clin Case Rep 2019; 7:311-315.
Tamboli M, Kitamura R, Ma W, et al. Preoperative ultrasound-guided botulinum toxin A injection facilitates closure of a complex abdominal wall hernia: a case report. A Tambala Pract 2019; 13:193-196.
Zielinski MD, Goussous N, Schiller HJ, Jenkins D. Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen. Hernia 2013; 17:101-107.
Bueno-Lledó J, Torregrosa A, Ballester N, et al. Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia. Hernia 2017; 21:233-243.
Bueno-Lledó J, Torregrosa A, Jimenez R, Pastor PG. Preoperative combination of progressive pneumoperitoneum and botulinum toxin type A in patients with loss of domain hernia. Surg Endosc 2018; 32:3599-3608.
Bueno-Lledó J, Carreño-Saenz O, Torregrosa-Gallud A, Pous-Serrano S. Preoperative botulinum toxin and progressive pneumoperitoneum in loss of domain hernias: our first 100 cases. Front Surg 2020; 7:3.
Ibarra-Hurtado TR, Nuno-Guzman CM, Echeagaray-Herrera JE, Robles-Velez E, de Jesus Gonzalez-Jaime J. Use of botulinum toxin type a before abdominal wall hernia reconstruction. World J Surg 2009; 33:2553-2556.
Ibarra-Hurtado TR, Nuno-Guzman CM, Miranda-Diaz AG, Troyo-Sanroman R, Navarro-Ibarra R, Bravo-Cuellar L. Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management. Hernia 2014; 18:647-652.
Nielsen MO, Bjerg J, Dorfelt A, Jorgensen LN, Jensen KK. Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain. Hernia 2020; 24:295-299.
Maloney SR, Schlosser KA, Prasad T, et al. Twelve years of component separation technique in abdominal wall reconstruction. Surgery 2019; 166:435-444.
Dressler D. Clinical applications of botulinum toxin. Curr Opin Microbiol 2012; 15:325-336.
Booth JH, Garvey PB, Baumann DP, et al. Primary fascial closure with mesh reinforcement is superior to bridged mesh repair for abdominal wall reconstruction. J Am Coll Surg 2013; 217:999-1009.